WCM
NVO

Windsor Capital Management’s Novo Nordisk NVO Stock Holding History

Windsor Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-340
Closed -$6K – 219
2013
Q4 		$6K Buy
+340
New +$5.92K ﹤0.01% 367

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Windsor Capital Management's NVO Position: Q1 2014 in Review

Windsor Capital Management sold out of Novo Nordisk (NVO) in Q1 2014, closing a stake of 340 shares — an estimated $6K sold.

Windsor Capital Management first reported a position in NVO in Q4 2013 and held it in 1 quarter. The position peaked at $6K in Q4 2013. 461 funds tracked by Wall St. Rank hold NVO as of Q1 2014.

  • Windsor Capital Management reported no remaining Novo Nordisk position as of Q1 2014 after selling out during the quarter.
  • Windsor Capital Management sold 340 Novo Nordisk shares in Q1 2014, an estimated $6K.
  • Windsor Capital Management first reported a position in Novo Nordisk in Q4 2013 and held it in 1 quarter.
  • Windsor Capital Management's Novo Nordisk position peaked at $6K in Q4 2013.
  • 461 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2014.

Based on Windsor Capital Management's 13F filing for Q1 2014, filed 28 Apr 2014.